Medical Article

The application of AI technology is part of a carefully orchestrated effort dependent on human intelligence, and the collaboration of physicians, disease-specific specialists, nurses, data scientists, and technologists. Done right, these efforts can lead to profound benefits, and offer a promising future for clinical research and patient care. The post Augmenting Brain Power: Real-World Data, Advanced…

Across the U.S., nearly 700 rural hospitals are at risk of closure. When they shut down, the impacts cascade: broken continuity, delayed care, and increased cyber risk in every new system a patient must navigate. The post The Hidden Fallout of Rural Hospital Closures: Patient Care Suffers – and So Does Data Security appeared first…

A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no future. The post Will the Arkansas PBM Law Survive A Judge’s Rejection? appeared first on MedCity News.

Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma. The drug came from Jazz’s $935 million acquisition of Chimerix earlier this year. The post Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug appeared first on MedCity News.